The Dog Aging Project

TriviumVet is delighted to be involved as a research collaborator with the Dog Aging Project, an innovative initiative that brings together a community of dogs, owners, veterinarians, researchers, and volunteers to carry out the most ambitious canine science project in the world. The Dog Aging Project has two fundamental goals: 1) Understanding how genes, lifestyle, and the environment influence aging, and 2) Intervening to increase “health span,” (the period of a dog’s life spent free from disease).

Our patented veterinary product TRIV202 (rapamycin) is being administered to a subset of the Dog Aging Project dogs to monitor its effect on age-related decline. This study is called TRIAD and further details can be found below.